Session Chair:
Sarah Phillips, Ipsos Health Division, UK
Age old vs. New age techniques;
when to embrace the thrill of the new
and when to ‘stick to the knitting’.Carolyn Chamberlain and Tracey Brader, Praxis Research &
Consulting, UK
Using a court room style approach, this paper will put techniques ‘on trial’.
It will (in a controversial and thought
provoking way), capture, challenge
and crystallize the role, use and contribution of ‘new age techniques’ (such as NLP and semiotics) Vs older,
more traditional, tried and tested techniques in the world of international pharmaceutical market research.
|
Session Chairs:
Anna Garofalo, Double Helix
Development, UK and Matthias
Weber, Solvay Pharmaceuticals,
Switzerland
Will Market Researchers be the Neanderthals of Homo Marketingus?
Henry Gazay, Medimix International
and Alex de Carvalho, Adjunct
Professor Social Media, University of
Miami, USA
This paper will explore the role of social and professional networking sites across the globe amongst medical professionals and will show how global patterns and specific regional variances will help pharmaceutical companies better focus their e-marketing strategies.
So, if you want to learn what skills market researchers need to avoid becoming the Neanderthals of Homo Marketingus, this paper will provide the answers. |
Session Chairs:
Peter Eichhorn, GfK and Bernd Heinrichs, Gruenenthal, Germany
Assessing the ‘value of knowing’ for reimbursement bodies. Koenraad Dierick, suAzio Consulting, Belgium and Teresa Zyczynski, GE
Healthcare, USA
In the context of the changing global healthcare landscape, this paper explores (through robust primary research) whether the ‘value of knowing’ that a patient suffers from a specific pathology impacts on the level of reimbursement for new drugs in the US. Prepare to be surprised. |
